{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T04:45:25Z","timestamp":1770525925811,"version":"3.49.0"},"reference-count":0,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,6,28]]},"DOI":"10.1182\/blood.v100.2.728","type":"journal-article","created":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T17:48:18Z","timestamp":1033494498000},"page":"728-730","source":"Crossref","is-referenced-by-count":108,"title":["Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura"],"prefix":"10.1182","volume":"100","author":[{"given":"S.","family":"Nomura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","container-title":["Blood"],"original-title":[],"deposited":{"date-parts":[[2011,8,22]],"date-time":"2011-08-22T10:58:58Z","timestamp":1314010738000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.bloodjournal.org\/cgi\/doi\/10.1182\/blood.V100.2.728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6,28]]},"references-count":0,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1182\/blood.v100.2.728","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,6,28]]}}}